Your browser doesn't support javascript.
loading
Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms
Soares, Moysés Antonio Porto; Oliveira, Rafael Daltro de; Cortopassi, Gabriel Macedo; Machado Neto, João Agostinho; Palma, Leonardo Carvalho; Pontes, Lorena Lobo de Figueiredo.
Afiliação
  • Soares, Moysés Antonio Porto; Universidade de São Paulo - USP. Centro de Terapia Celular. Faculdade de Medicina. Ribeirão Preto. BR
  • Oliveira, Rafael Daltro de; Universidade de São Paulo - USP. Centro de Terapia Celular. Faculdade de Medicina. Ribeirão Preto. BR
  • Cortopassi, Gabriel Macedo; Universidade de São Paulo - USP. Centro de Terapia Celular. Faculdade de Medicina. Ribeirão Preto. BR
  • Machado Neto, João Agostinho; Universidade de São Paulo - USP. Centro de Terapia Celular. Faculdade de Medicina. Ribeirão Preto. BR
  • Palma, Leonardo Carvalho; Universidade de São Paulo - USP. Centro de Terapia Celular. Faculdade de Medicina. Ribeirão Preto. BR
  • Pontes, Lorena Lobo de Figueiredo; Universidade de São Paulo. Centro de Terapia Celular. Faculdade de Medicina. Ribeirão Preto. BR
Hematol., Transfus. Cell Ther. (Impr.) ; 42(3): 238-244, July-Sept. 2020. tab, graf
Article em En | LILACS | ID: biblio-1134042
Biblioteca responsável: BR408.1
Localização: BR408.1
ABSTRACT
ABSTRACT

Background:

The classical BCR-ABL1-negative myeloproliferative neoplasms (MPNs) are Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF). In developing countries, there are few reports that truly reveal the clinical setting of these patients. Therefore, we aimed to characterize a single center MPN population with a special focus on the correct diagnosis based on the recent review of the WHO criteria for the diagnosis of myeloid neoplasms.

Methods:

This retrospective study analyzed data from medical records of patients with classical BCR-ABL1-negative MPNs diagnosed from January 1997 to October 2017 and followed at the University Hospital of Ribeirão Preto Medical School.

Results:

A total of 162 patients were assessed, 61 with PV, 50 with ET, and 51 with PMF. The mutational status analysis revealed that 113 (69.3%) harbored the JAK2V617F mutation, 23 (14.1%), the CALR mutation, and 12 (7.4%) had a triple-negative status. None of the patients were found to have mutations on the thrombopoietin receptor gene (MPL), including some ET and PMF patients who were not tested. Among the PV patients, 57 (93.5%) were positive for the JAK2V617F mutation, one (1.6%) presented an in-frame deletion JAK2 exon 12 mutation and one (1.6%) presented a missense JAK2 exon 9 mutation, not previously described. The overall survival was lower in the triple-negative patients with PMF, when compared to the JAK2V617F or CALR-mutated (p= 0.002).

Conclusion:

The frequency of somatic mutations and survival in our cohort, stratified according to the respective disease, was consistent with the literature data, despite some limitations. Further prospective epidemiological studies of MPN cohorts are encouraged in developing countries.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: LILACS Assunto principal: Policitemia Vera / Leucemia Mieloide Crônica Atípica BCR-ABL Negativa / Mielofibrose Primária / Trombocitemia Essencial / Transtornos Mieloproliferativos Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Hematol., Transfus. Cell Ther. (Impr.) Assunto da revista: Hematologia / TransfusÆo de Sangue Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: LILACS Assunto principal: Policitemia Vera / Leucemia Mieloide Crônica Atípica BCR-ABL Negativa / Mielofibrose Primária / Trombocitemia Essencial / Transtornos Mieloproliferativos Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Hematol., Transfus. Cell Ther. (Impr.) Assunto da revista: Hematologia / TransfusÆo de Sangue Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil